S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

BPMC Blueprint Medicines Corporation

88.35

1.15 (1.32%)

After Hours

Last Updated: 19:00:00

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines Corporation News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 18 December 2024 (3 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
Saturday 7 December 2024 (4 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 2 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 29 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 27 November 2024 (1 month ago) • Edgar (US Regulatory)

More Blueprint Medicines Corporation News Articles

INTESA SANPAOLO

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions